NSE - Delayed Quote INR

Torrent Pharmaceuticals Limited (TORNTPHARM.NS)

3,248.40
-10.40
(-0.32%)
At close: June 13 at 3:29:57 PM GMT+5:30
Currency in INR All numbers in thousands
Download
Breakdown
TTM
3/31/2025
3/31/2024
3/31/2023
3/31/2022
Total Revenue
113,170,000
113,170,000
105,620,000
94,636,900
84,188,000
Cost of Revenue
27,760,000
27,760,000
26,860,000
28,276,900
25,374,700
Gross Profit
85,410,000
85,410,000
78,760,000
66,360,000
58,813,300
Operating Expense
56,150,000
56,150,000
53,160,000
44,959,800
41,119,900
Operating Income
29,260,000
29,260,000
25,600,000
21,400,200
17,693,400
Net Non Operating Interest Income Expense
-2,520,000
-2,520,000
-3,540,000
-3,186,600
-2,479,100
Pretax Income
26,730,000
26,730,000
23,520,000
18,471,600
12,259,100
Tax Provision
7,620,000
7,620,000
6,960,000
6,019,300
4,487,300
Net Income Common Stockholders
19,110,000
19,110,000
16,560,000
12,452,300
7,771,800
Diluted NI Available to Com Stockholders
19,110,000
19,110,000
16,560,000
12,452,300
7,771,800
Basic EPS
56.47
56.47
48.94
36.79
22.96
Diluted EPS
56.47
56.47
48.94
36.79
22.96
Basic Average Shares
338,409.78
338,409.78
338,373.52
338,445.44
338,445.44
Diluted Average Shares
338,409.78
338,409.78
338,373.52
338,445.44
338,445.44
Total Expenses
83,910,000
83,910,000
80,020,000
73,236,700
66,494,600
Net Income from Continuing & Discontinued Operation
19,110,000
19,110,000
16,560,000
12,452,300
7,771,800
Normalized Income
19,281,582.49
19,281,582.49
15,940,408.16
12,205,781.63
10,781,968.60
Interest Income
--
--
114,800
147,800
71,500
Interest Expense
2,520,000
2,520,000
3,540,000
3,322,400
2,529,300
Net Interest Income
-2,520,000
-2,520,000
-3,540,000
-3,186,600
-2,479,100
EBIT
29,250,000
29,250,000
27,060,000
21,794,000
14,788,400
EBITDA
37,200,000
37,200,000
35,140,000
28,814,300
21,407,700
Reconciled Cost of Revenue
27,760,000
27,760,000
26,860,000
28,276,900
25,374,700
Reconciled Depreciation
7,950,000
7,950,000
8,080,000
7,020,300
6,619,300
Net Income from Continuing Operation Net Minority Interest
19,110,000
19,110,000
16,560,000
12,452,300
7,771,800
Total Unusual Items Excluding Goodwill
-240,000
-240,000
880,000
365,700
-4,747,900
Total Unusual Items
-240,000
-240,000
880,000
365,700
-4,747,900
Normalized EBITDA
37,440,000
37,440,000
34,260,000
28,448,600
26,155,600
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-68,417.51
-68,417.51
260,408.16
119,181.63
-1,737,731.40
3/31/2022 - 7/1/2002

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ALKEM.NS Alkem Laboratories Limited
4,850.50
+0.08%
 
IPCALAB.NS Ipca Laboratories Limited
1,368.00
-1.08%
 
AUROPHARMA.NS Aurobindo Pharma Limited
1,147.90
-0.63%
 
LUPIN.NS Lupin Limited
1,997.80
-1.26%
 
AJANTPHARM.NS Ajanta Pharma Limited
2,632.70
-3.57%
 
CIPLA.NS Cipla Limited
1,507.80
+0.33%
 
DRREDDY.NS Dr. Reddy's Laboratories Limited
1,363.00
+0.02%
 
LUPIN.BO Lupin Limited
2,004.85
-0.86%
 
MANKIND.NS Mankind Pharma Limited
2,380.00
-0.42%
 
DIVISLAB.NS Divi's Laboratories Limited
6,670.00
-0.82%